{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:11:38Z","timestamp":1788945098639,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bbagen.2023.130486","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T11:17:13Z","timestamp":1696677433000},"page":"130486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight"],"prefix":"10.1016","volume":"1867","author":[{"given":"Marutpong","family":"Detarya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panupong","family":"Mahalapbutr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orawan","family":"Waenphimai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonexai","family":"Kidoikhammouan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somkid","family":"Janeklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanlayanee","family":"Sawanyawisuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulthida","family":"Vaeteewoottacharn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wunchana","family":"Seubwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charupong","family":"Saengboonmee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerawut","family":"Thothaisong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wachirachai","family":"Pabuprapap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichart","family":"Suksamrarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopit","family":"Wongkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2023.130486_bb0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbagen.2023.130486_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7314\/APJCP.2016.17.1.401","article-title":"Cholangiocarcinoma patient outcome in northeastern Thailand: single-center prospective study","volume":"17","author":"Luvira","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbagen.2023.130486_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/theoncologist.2007-0252","article-title":"Systemic therapy for biliary tract cancers","volume":"13","author":"Hezel","year":"2008","journal-title":"Oncologist"},{"issue":"Suppl","key":"10.1016\/j.bbagen.2023.130486_bb0025","first-page":"3","article-title":"Systemic therapy for locally advanced and metastatic cholangiocarcinoma","volume":"13","author":"Sookprasert","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"Suppl. 2","key":"10.1016\/j.bbagen.2023.130486_bb0030","article-title":"The role of chemotherapy in cholangiocarcinoma","volume":"16","author":"Thongprasert","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2023.130486_bb0040","first-page":"1264","article-title":"Phytochemical and pharmacological activity of Tiliacora triandra (Colebr.) Diels, Songklanakarin J","volume":"43","author":"Nutmakul","year":"2021","journal-title":"Sci. Technol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jep.2014.11.038","article-title":"In vitro anti-proliferative activity on colon cancer cell line (HT-29) of Thai medicinal plants selected from Thai\/Lanna medicinal plant recipe database \"MANOSROI III\"","volume":"161","author":"Manosroi","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5530\/pj.2016.1.1","article-title":"Chemical constituents and in vitro anticancer activity of Tiliacora triandra leaves","volume":"8","author":"Rattana","year":"2016","journal-title":"Phcog. J."},{"key":"10.1016\/j.bbagen.2023.130486_bb0055","article-title":"Cytotoxicity to five cancer cell lines of the respiratory tract system and anti-inflammatory activity of thai traditional remedy","volume":"14","author":"Juckmeta","year":"2019","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bbagen.2023.130486_bb0060","doi-asserted-by":"crossref","first-page":"112409","DOI":"10.1016\/j.jep.2019.112409","article-title":"In vitro protective effects of plants frequently used traditionally in cancer prevention in Thai traditional medicine: an ethnopharmacological study","volume":"250","author":"Lumlerdkij","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0065","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14518","article-title":"Ethanolic extract of Ya-nang (Tiliacora triandra) leaf powder induces apoptosis in cholangiocarcinoma cell lines via induction of hyperacetylation and inhibition of growth signaling","volume":"10","author":"Samankul","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.bbagen.2023.130486_bb0070","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.7314\/APJCP.2014.15.17.7473","article-title":"In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma","volume":"15","author":"Janeklang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbagen.2023.130486_bb0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13577-020-00334-w","article-title":"Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient","volume":"33","author":"Sripa","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bbagen.2023.130486_bb0080","doi-asserted-by":"crossref","first-page":"120648","DOI":"10.1016\/j.lfs.2022.120648","article-title":"Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis","volume":"302","author":"Thamrongwaranggoon","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbagen.2023.130486_bb0085","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1071\/CH9812001","article-title":"Alkaloids of Tiliacora triandra","volume":"34","author":"Wiriyachitra","year":"1981","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.bbagen.2023.130486_bb0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2006-962491","article-title":"New bisbenzylisoquinoline alkaloids from Tiliacora triandra","volume":"54","author":"Pachaly","year":"1988","journal-title":"Planta Med."},{"key":"10.1016\/j.bbagen.2023.130486_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/glycob\/cwz098","article-title":"The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT\/ERK signaling","volume":"30","author":"Detarya","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2023.130486_bb0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2023.130486_bb0105","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","article-title":"Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells","volume":"109","author":"Bhardwaj","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2023.130486_bb0110","first-page":"945","article-title":"Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention","volume":"8","author":"Buettner","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2023.130486_bb0115","first-page":"4140","article-title":"Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight","volume":"12","author":"Detarya","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbagen.2023.130486_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/mol.107.034827","article-title":"Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1\/S phase arrest in human non-small-cell lung cancer cell lines","volume":"72","author":"Ling","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0125","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/jm301762v","article-title":"Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases","volume":"56","author":"Addie","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2023.130486_bb0130","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1021\/acs.jmedchem.1c01180","article-title":"Structure-based design of potent, selective, and orally bioavailable VPS34 kinase inhibitors","volume":"65","author":"Hu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2023.130486_bb0135","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbagen.2023.130486_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42826-019-0030-0","article-title":"Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad","volume":"35","author":"Kang","year":"2019","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bbagen.2023.130486_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2023.130486_bb0150","doi-asserted-by":"crossref","first-page":"154678","DOI":"10.1016\/j.prp.2023.154678","article-title":"BI6727 and GSK461364A, potent PLK1 inhibitors induce G2\/M arrest and apoptosis against cholangiocarcinoma cell lines","volume":"248","author":"Riantana","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbagen.2023.130486_bb0155","doi-asserted-by":"crossref","first-page":"174899","DOI":"10.1016\/j.ejphar.2022.174899","article-title":"Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells","volume":"922","author":"Waenphimai","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0160","doi-asserted-by":"crossref","first-page":"108590","DOI":"10.1016\/j.abb.2020.108590","article-title":"Characterization of dye-decolorizing peroxidase from Bacillus subtilis","volume":"693","author":"Dhankhar","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2023.130486_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132476","article-title":"Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus","volume":"1255","author":"Kumari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbagen.2023.130486_bb0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijbiomac.2021.10.100","article-title":"Structure of dye-decolorizing peroxidase from Bacillus subtilis in complex with veratryl alcohol","volume":"193","author":"Dhankhar","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0175","doi-asserted-by":"crossref","first-page":"17881","DOI":"10.1021\/acsomega.2c01188","article-title":"Discovery of anilino-1,4-naphthoquinones as potent EGFR tyrosine kinase inhibitors: synthesis, biological evaluation, and comprehensive molecular modeling","volume":"7","author":"Mahalapbutr","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbagen.2023.130486_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040437","article-title":"Butoxy Mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: combined experimental and theoretical investigations","volume":"11","author":"Mahalapbutr","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbagen.2023.130486_bb0185","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1080\/07391102.2020.1839558","article-title":"Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel","volume":"40","author":"Kumari","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbagen.2023.130486_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbagen.2023.130486_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2023.130486_bb0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/acschembio.5b00945","article-title":"Strategies and approaches of targeting STAT3 for cancer treatment","volume":"11","author":"Furtek","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbagen.2023.130486_bb0210","article-title":"Screening of potent STAT3-SH2 domain inhibitors from JAK\/STAT compound library through molecular dynamics simulation","author":"Manoharan","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bbagen.2023.130486_bb0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/abbs\/gmaa177","article-title":"Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma","volume":"53","author":"Wang","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.bbagen.2023.130486_bb0220","article-title":"Overcome drug resistance in cholangiocarcinoma: new insight into mechanisms and refining the preclinical experiment models","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523001848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416523001848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:18:54Z","timestamp":1759637934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416523001848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0304416523001848"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130486","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2023.130486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130486"}}